Incidence, 169/ colorectal 1.25 (0.86-1.82) cancer, Igfbp 1 gene methylated Incidence, colorectal 112/ cancer, Igfbp 3 1.26 (0.78-2.04) genes methylated Incidence, colorectal 104/ cancer, 0 0.91 (0.57-1.43) genes methylated FHS-Offspring Cohort, Parekh, 2013 93/ Death certificate circumference substantially Age, sex, Prospective Incidence, colon Used in HvsL COL40991 4 615 and medical was measured increased risk vs 1.08 (0.50-2.35) alcohol, BMI, Cohort, cancer analysis only USA 37 records by trained normal smoking status Age: 20- years, personnel M/W Age, alcohol, WHI, BMI, Prospective 2012 1 181/ Self-reported educational Superseded by Cohort, Incidence, colon COL40901 141 652 verified by Measured per 1 SD units 1.28 Income, Kabat, 2012 Age: 50-79 cancer USA 8 years medical record physical COL40898 years, activity, race, W region, smoking,
169/ Incidence, colorectal cancer, Igfbp 1 gene methylated 1.25 (0.86-1.82) 112/ Incidence, colorectal cancer, Igfbp 3 genes methylated 1.26 (0.78-2.04) 104/ Incidence, colorectal cancer, 0 genes methylated 0.91 (0.57-1.43) Parekh, 2013 COL40991 USA FHS-Offspring Cohort, Prospective Cohort, Age: 20- years, M/W 93/ 4 615 37 Death certificate and medical records circumference was measured by trained personnel Incidence, colon cancer substantially increased risk vs normal 1.08 (0.50-2.35) Age, sex, alcohol, BMI, smoking status Used in HvsL analysis only 2012 COL40901 USA WHI, Prospective Cohort, Age: 50-79 years, W 1 181/ 141 652 8 years Self-reported verified by medical record Measured Incidence, colon cancer per 1 SD units 1.28 Age, alcohol, BMI, educational Income, physical activity, race, region, smoking, Superseded by Kabat, 2012 COL40898